期刊文献+

OSTP-DDP靶向抑制卵巢癌A2780细胞生长作用的研究 被引量:1

The inhibitory effect of OSTP-DDP on the growth of ovarian cancer A2780 cells
下载PDF
导出
摘要 目的研究卵巢癌特异性结合肽(ovarian cancer specific targeting peptide,OSTP)与顺铂(cis-dichlorodiamineplatinum,DDP)偶联物(OSTP-DDP)对卵巢癌A2780细胞的靶向抑制作用。方法化学合成OSTP-DDP,体外培养卵巢癌A2780细胞,采用CCK-8法分别检测OSTP-DDP和DDP对卵巢癌A2780细胞的生长抑制作用;通过Annexin V-FITC凋亡试剂盒分别检测OSTP-DDP和DDP对卵巢癌A2780细胞的周期和凋亡作用。结果通过质谱分析和高效液相色谱(HPLC)分析,提示成功合成OSTP-DDP。CCK-8法检测显示,OSTP-DDP与DDP分别以不同浓度(10、20、40、80、160、320μmol·L^(-1))处理卵巢癌A2780细胞24、48、72 h后,均可对该细胞的生长起到抑制作用,且呈时间、浓度依赖性。且OSTP-DDP的作用强于DDP(P<0.05),提示OSTP-DDP具有靶向抑制细胞生长作用。流式细胞术检测结果显示,经OSTP-DDP和DDP处理后,细胞周期均被阻滞于G_1期,作用72 h后,OSTP-DDP对卵巢癌A2780细胞的周期抑制作用强于DDP,差异具有统计学意义(P<0.05)。作用24、48、72 h后,OSTP-DDP对卵巢癌A2780细胞凋亡的作用强于DDP(P<0.01)差异具有统计学意义,提示OSTP-DDP具有较强的靶向诱导细胞凋亡作用。结论 OSTP-DDP对卵巢癌A2780细胞的生长具有靶向抑制作用,OSTP作为化疗药物靶向载体治疗卵巢癌有良好的应用前景。 Aim To study the growth inhibitory effect of the conjugate(ovarian cancer specific targeting peptide and cisplatin,OSTP-DDP) that targeting ovarian cancer cells A2780.Methods Using chemical method to synthesize OSTP-DDP,ovarian cancer cells A2780 were cultured in vitro,using CCK-8 method(Cell Counting Kit-8) to detect the growth inhibitory effect of ovarian cancer A2780 cells,which were disposed by OSTP-DDP and DDP.Annexin V-FITC was used to detect the cycle and apoptosis effect of ovarian cancer A2780 cells which were disposed by OSTP-DDP and DDP.Results According to the mass spectrometry and the high performance liquid chromatography(HPLC) analysis,OSTP-DDP was proved to synthesize successfully.CCK-8 assay showed that both OSTP-DDP and DDP could play the growth inhibitory effect and showed a concentration-dependent manner when cells were treated in different concentrations(10,20,40,80,160,320 μmol·L^(-1)) respectively after 24 h,48 h,72 h.And the effect of OSTP-DDP was stronger than DDP(P<0.05),indicated OSTP-DDP had targeted cytostatic effect.The result of the flow cytometry showed that cell cycle was mostly arrested in G_1 phase after 72 h treated by OSTP-DDP and DDP,the inhibitory effect of OSTP-DDP was stronger than DDP(P <0.05).The apoptosis effect of OSTP-DDP was stronger than DDP(P <0.01),suggested that OSTP-DDP had a stronger targeting apoptosis-inducing effect.Conclusion OSTP-DDP has the targeting growth inhibitory effect on the ovarian cancer cell A2780,OSTP as a chemotherapeutic drug targeting vector has a great prospect to treat ovarian cancer.
出处 《中国药理学通报》 CAS CSCD 北大核心 2016年第2期204-210,共7页 Chinese Pharmacological Bulletin
基金 国家自然科学基金资助项目(No 81472449 81101988)
关键词 卵巢癌A2780细胞 OSTPDDP DDP 增殖抑制 凋亡 靶向治疗 ovarian cancer cell A2780 ovarian cancer specific targeting peptide(OSTP) and cisplatin(DDP) DDP growth inhibition apoptosis targeting therapy
  • 相关文献

参考文献1

二级参考文献22

  • 1Maria Ausiliatrice Puglisi,Valentina Tesori,Wanda Lattanzi,Giovanni Battista Gasbarrini,Antonio Gasbarrini.Colon cancer stem cells:Controversies and perspectives[J].World Journal of Gastroenterology,2013,19(20):2997-3006. 被引量:5
  • 2Jean Paul Thiery,Hervé Acloque,Ruby Y.J. Huang,M. Angela Nieto.Epithelial-Mesenchymal Transitions in Development and Disease[J]. Cell . 2009 (5)
  • 3Krishnansu Tewari,Ramez N Eskander.Epithelial cell-adhesion molecule-directed trifunctional antibody immunotherapy for symptom management of advanced ovarian cancer[J]. Clinical Pharmacology: Advances and Applications . 2013 (Supplement 1)
  • 4Amy P.N. Skubitz,Elizabeth P. Taras,Kristin L.M. Boylan,Nate N. Waldron,Seunguk Oh,Angela Panoskaltsis-Mortari,Daniel A. Vallera.Targeting CD133 in an in vivo ovarian cancer model reduces ovarian cancer progression[J]. Gynecologic Oncology . 2013
  • 5Hongmei Sun,Jun Jia,Xiaoli Wang,Bo Ma,Lijun Di,Guohong Song,Jun Ren.CD44 + /CD24 ? breast cancer cells isolated from MCF-7 cultures exhibit enhanced angiogenic properties[J]. Clinical and Translational Oncology . 2013 (1)
  • 6Jessica J. Shank,Kun Yang,Jacob Ghannam,Lourdes Cabrera,Carolyn J. Johnston,R. Kevin Reynolds,Ronald J. Buckanovich.Metformin targets ovarian cancer stem cells in vitro and in vivo[J]. Gynecologic Oncology . 2012 (2)
  • 7Ignacio Romero Noguera,Charlotte C. Sun,Russell R. Broaddus,Donna Branham,Charles F. Levenback,Pedro T. Ramirez,Anil K. Sood,Robert L. Coleman,David M. Gershenson.Phase II trial of imatinib mesylate in patients with recurrent platinum- and taxane-resistant low-grade serous carcinoma of the ovary, peritoneum, or fallopian tube[J]. Gynecologic Oncology . 2012 (3)
  • 8Lijing Luo,Jianfang Zeng,Bing Liang,Zhe Zhao,Lulu Sun,Dongyan Cao,Jiaxin Yang,Keng Shen.Ovarian cancer cells with the CD117 phenotype are highly tumorigenic and are related to chemotherapy outcome[J]. Experimental and Molecular Pathology . 2011 (2)
  • 9Anasuya Ray,Erhong Meng,Eddie Reed,Lalita Shevde,Rodney Rocconi.Hedgehog signaling pathway regulates the growth of ovarian cancer spheroidforming cells[J]. International Journal of Oncology . 2011 (4)
  • 10Markus M.Heiss,PawelMurawa,PiotrKoralewski,ElzbietaKutarska,Olena O.Kolesnik,Vladimir V.Ivanchenko,Alexander S.Dudnichenko,BiruteAleknaviciene,ArturasRazbadauskas,MartinGore,ElenaGanea‐Motan,TudorCiuleanu,PaulineWimberger,AlexanderSchmittel,BarbaraSchmalfeldt,AlexanderBurges,CarstenBokemeyer,HorstLindhofer,AngelikaLahr,Simon L.Parsons.The trifunctional antibody catumaxomab for the treatment of malignant ascites due to epithelial cancer: Results of a prospective randomized phase II/III trial[J]. Int. J. Cancer . 2010 (9)

共引文献6

同被引文献2

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部